Healthcare Pharmaceutical manufacturing Retail Sales 
PM360
NOVEMBER 14, 2023
In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. retail pharmacies to access a 30-day supply of Lantus for only $35. for only $35.
Pharmaceutical Technology
SEPTEMBER 15, 2022
The growing demand from customers and pressures from global competitors have increased the significance of active pharmaceutical ingredients (API) chemical companies in the pharmaceutical industry supply chain.
European Pharmaceutical Review
NOVEMBER 8, 2022
For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D.
Expert insights. Personalized for you.
52 
Let's personalize your content